Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Instituto Nacional de Cardiología
Ciudad de México, MéxicoPublicaciones en colaboración con investigadores/as de Instituto Nacional de Cardiología (24)
2024
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1821-1831
-
Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study
Circulation: Heart Failure, Vol. 17, Núm. 1, pp. E011105
-
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1839-1849
2023
-
Impact of Complete Revascularization in the ISCHEMIA Trial
Journal of the American College of Cardiology, Vol. 82, Núm. 12, pp. 1175-1188
-
Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial
JACC: Heart Failure, Vol. 11, Núm. 12, pp. 1729-1738
2022
-
Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial
American Heart Journal, Vol. 248, pp. 72-83
-
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
Heart Rhythm, Vol. 19, Núm. 7, pp. e1-e60
-
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Journal of Arrhythmia, Vol. 38, Núm. 4, pp. 491-553
-
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 8, pp. 1307-1367
-
Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy
Hellenic Journal of Cardiology, Vol. 67, pp. 9-18
-
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
New England Journal of Medicine, Vol. 387, Núm. 11, pp. 978-988
2021
-
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116
-
Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: The ESC EORP Cardiomyopathy/Myocarditis Registry
European Heart Journal Cardiovascular Imaging, Vol. 22, Núm. 7, pp. 781-789
-
Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes
International Journal of Cardiovascular Imaging, Vol. 37, Núm. 3, pp. 953-964
-
MYH7 p.Glu903Gln Is a Pathogenic Variant Associated With Hypertrophic Cardiomyopathy
Circulation: Genomic and Precision Medicine, Vol. 14, Núm. 5, pp. E003476
-
Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
ESC Heart Failure, Vol. 8, Núm. 6, pp. 4685-4692
-
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging
Journal of Clinical Medicine, Vol. 10, Núm. 16
2020
-
Initial invasive or conservative strategy for stable coronary disease
New England Journal of Medicine, Vol. 382, Núm. 15, pp. 1395-1407
-
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171